Nursing School, Biella Hospital, University of Piemonte Orientale, Italy.
Eur J Oncol Nurs. 2011 Dec;15(5):377-81. doi: 10.1016/j.ejon.2010.11.007. Epub 2010 Dec 16.
The principal aim of this study is to analyze the incidence of late complications in oncologic patients with totally implanted central venous access ports.
A prospective multicenter observational study was conducted in 26 Italian oncologic outpatient clinics. 1076 cancer patients with Totally Implanted Central Venous Access Ports (TIAP) were observed. 515 devices were observed in patients under treatment and 561 in patients who went to the outpatient clinic only for flushing.
Late complications observed in patients under treatment were: 3 pocket infections (0.09/1000 days of port observation), 1 cutaneous infection (0.03/1000 days of port observation), 8 occlusions (0.24/1000 days of port observation) and 12 others. In patients using the device only for flushing we observed 4 cases of device related bacteremia (0.04/1000 days of port observation), 1 pocket infection (0.01/1000 days of port observation), 1 cutaneous infection (0.01/1000 days of port observation), 3 occlusions (0.03/1000 days of port observation) and 7 other complications.
The low incidence of complications suggests that TIAP is safe and reliable for long term intermittent venous access. Our results support the use of TIAP in the oncology patients.
本研究的主要目的是分析完全植入式中心静脉通路端口的肿瘤患者的晚期并发症发生率。
在 26 家意大利肿瘤门诊进行了一项前瞻性多中心观察性研究。观察了 1076 例患有完全植入中央静脉通路端口（TIAP）的癌症患者。515 个设备用于正在治疗的患者，561 个设备用于仅来门诊冲洗的患者。
正在治疗的患者中观察到的晚期并发症包括：3 例袋感染（0.09/1000 天端口观察），1 例皮肤感染（0.03/1000 天端口观察），8 例阻塞（0.24/1000 天端口观察）和 12 例其他并发症。在仅使用该设备冲洗的患者中，我们观察到 4 例与设备相关的菌血症（0.04/1000 天端口观察），1 例袋感染（0.01/1000 天端口观察），1 例皮肤感染（0.01/1000 天端口观察），3 例阻塞（0.03/1000 天端口观察）和 7 例其他并发症。
并发症发生率低表明 TIAP 可安全可靠地用于长期间歇性静脉通路。我们的结果支持 TIAP 在肿瘤患者中的使用。
Zotero 插件